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Background:  Abnormal left ventricular diastolic function is an early sign of cardiac dysfunction caused by obesity, diabetes and ageing, and a 
common feature of obesity, diabetes and ageing is glutathione reduction. Left ventricular diastolic dysfunction serves as an important marker of 
cardiovascular risk.
Methods: To clarify the mechanism of left ventricular diastolic dysfunction, we examined the effect of 1) glutathione synthesis inhibitor DL-
buthionine (S,R)-sulfoximine (BSO) (30 mM/L in drinking water); 2) BSO+Rac1 inhibitor (NSC23766 10 mg/kg per day i.p.) and 3) BSO+Rho kinase 
inhibitor (fasudil 15mg/kg per day SC) in salt (8% NaCl)-loaded Sprague-Dawley rats. Left ventricular diastolic function was monitored by measuring 
deceleration time of mitral early inflow and -dP/dt, the time constant by echocardiography or cardiac catheterization.
Results:  Although systolic function was similar to the control rats in all the groups, BSO deteriorated left ventricular diastolic function. Rac1 
activity but not RhoA activity increased in BSO loading rats. The expression of sarcoendoplasmic reticulum Ca2+-ATPase 1 (SERCA1), which 
correlated with the cardiac dysfunction, did not change among groups, whereas the phosphorylation of phospholamban (Ser16 and Thr17), 
which kept the activity of SERCA1, decreased with BSO loading. Rac1 inhibition but not Rho kinase inhibition preserved the phosphorylation of 
phospholamban and the diastolic function.
Conclusions:  These results suggest that glutathione reduction causes left ventricular diastolic dysfunction through Rac1 activation- 
phospholamban phosphorylation inhibition-SERCA1 inactivation pathway. Rac1 may be an important target in treatment of left ventricular diastolic 
dysfunction.
